Michel Pierres

Title: Michel Pierres: Innovator in Monoclonal Antibodies

Introduction

Michel Pierres is a notable inventor based in Marseille, France. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has implications for both therapeutic and diagnostic applications.

Latest Patents

Michel Pierres' latest patents focus on monoclonal antibodies that bind to the B7 family member B7H6. These antibodies are capable of inhibiting the interaction of B7H6 with NKp30. Additionally, he has developed anti-B7H6 antibody-drug conjugates, which consist of an anti-B7H6 monoclonal antibody conjugated to a therapeutic agent. These innovations are useful in exerting therapeutic effects against B7H6-expressing cells and in diagnostic methods for detecting B7H6 or B7H6-expressing cells.

Career Highlights

Throughout his career, Michel Pierres has worked with prestigious organizations such as the National Institute of Health and Medical Research and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Some of his notable coworkers include Eric Vivier and Myriam Baratin. Their collaborative efforts have further enhanced the impact of his research in the field of monoclonal antibodies.

Conclusion

Michel Pierres stands out as an influential inventor in the biotechnology sector, particularly for his advancements in monoclonal antibodies. His work continues to pave the way for innovative therapeutic and diagnostic solutions.